Arrow Alexander K. 4

4 · Protagenic Therapeutics, Inc.\new · Filed May 18, 2022

Insider Transaction Report

Form 4
Period: 2022-05-17
Arrow Alexander K.
Chief Financial Officer
Transactions
  • Purchase

    PTIX Common Stock

    2022-05-17$0.71/sh+23,000$16,330143,260 total
  • Purchase

    PTIX Common Stock

    2022-05-18$0.72/sh+8,000$5,760151,260 total

Documents

1 file
  • 4
    ownership.xmlPrimary